206 related articles for article (PubMed ID: 37236425)
1. Advances in development of exosomes for ophthalmic therapeutics.
Tian Y; Zhang T; Li J; Tao Y
Adv Drug Deliv Rev; 2023 Aug; 199():114899. PubMed ID: 37236425
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of Exosomes-An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics.
Morishita M; Takahashi Y; Nishikawa M; Takakura Y
J Pharm Sci; 2017 Sep; 106(9):2265-2269. PubMed ID: 28283433
[TBL] [Abstract][Full Text] [Related]
3. Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications.
Tian J; Han Z; Song D; Peng Y; Xiong M; Chen Z; Duan S; Zhang L
Int J Nanomedicine; 2023; 18():7923-7940. PubMed ID: 38152837
[TBL] [Abstract][Full Text] [Related]
4. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
Yamashita T; Takahashi Y; Takakura Y
Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
[TBL] [Abstract][Full Text] [Related]
5. A review on the use of extracellular vesicles for the delivery of drugs and biological therapeutics.
Amina SJ; Azam T; Dagher F; Guo B
Expert Opin Drug Deliv; 2024; 21(1):45-70. PubMed ID: 38226932
[TBL] [Abstract][Full Text] [Related]
6. Advances in exosome therapies in ophthalmology-From bench to clinical trial.
Sanghani A; Andriesei P; Kafetzis KN; Tagalakis AD; Yu-Wai-Man C
Acta Ophthalmol; 2022 May; 100(3):243-252. PubMed ID: 34114746
[TBL] [Abstract][Full Text] [Related]
7. Roles of Exosomes in Ocular Diseases.
Liu J; Jiang F; Jiang Y; Wang Y; Li Z; Shi X; Zhu Y; Wang H; Zhang Z
Int J Nanomedicine; 2020; 15():10519-10538. PubMed ID: 33402823
[TBL] [Abstract][Full Text] [Related]
8. Manufacturing Therapeutic Exosomes: from Bench to Industry.
Ahn SH; Ryu SW; Choi H; You S; Park J; Choi C
Mol Cells; 2022 May; 45(5):284-290. PubMed ID: 35534190
[TBL] [Abstract][Full Text] [Related]
9. Functionalized exosome harboring bioactive molecules for cancer therapy.
Kim YK; Choi Y; Nam GH; Kim IS
Cancer Lett; 2020 Oct; 489():155-162. PubMed ID: 32623071
[TBL] [Abstract][Full Text] [Related]
10. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
Srinivas L; S D; Kgk D; Malla RR
Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
[TBL] [Abstract][Full Text] [Related]
11. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
[TBL] [Abstract][Full Text] [Related]
12. Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate.
Shao J; Zaro J; Shen Y
Int J Nanomedicine; 2020; 15():9355-9371. PubMed ID: 33262592
[TBL] [Abstract][Full Text] [Related]
13. Exosomes as New Biomarkers and Drug Delivery Tools for the Prevention and Treatment of Various Diseases: Current Perspectives.
Liu Q; Li S; Dupuy A; Mai HL; Sailliet N; Logé C; Robert JH; Brouard S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360530
[TBL] [Abstract][Full Text] [Related]
14. Exosome engineering in cell therapy and drug delivery.
Sadeghi S; Tehrani FR; Tahmasebi S; Shafiee A; Hashemi SM
Inflammopharmacology; 2023 Feb; 31(1):145-169. PubMed ID: 36609717
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
[TBL] [Abstract][Full Text] [Related]
16. Development and regulation of exosome-based therapy products.
Batrakova EV; Kim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
[TBL] [Abstract][Full Text] [Related]
17. Current Knowledge and Future Perspectives of Exosomes as Nanocarriers in Diagnosis and Treatment of Diseases.
Zou Z; Li H; Xu G; Hu Y; Zhang W; Tian K
Int J Nanomedicine; 2023; 18():4751-4778. PubMed ID: 37635911
[TBL] [Abstract][Full Text] [Related]
18. Exosome-based delivery nanoplatforms: next-generation theranostic platforms for breast cancer.
Zheng Y; Li M; Weng B; Mao H; Zhao J
Biomater Sci; 2022 Mar; 10(7):1607-1625. PubMed ID: 35188522
[TBL] [Abstract][Full Text] [Related]
19. Exosome-like systems: Nanotechnology to overcome challenges for targeted cancer therapies.
García-Fernández J; Fuente Freire M
Cancer Lett; 2023 May; 561():216151. PubMed ID: 37001751
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Exosomes as the Next-Generation Bio-Shuttles: The Next Biggest Approach against Th17 Cell Catastrophe.
Samarpita S; Li X
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
